Trinity, Ontada use analytics, insights to boost oncology outreach
Trinity Life Sciences, a leader in advisory, insights, and analytics for the life sciences industry, has announced a strategic collaboration with Ontada, a McKesson business specializing in real-world oncology data, clinical education, and point-of-care technologies.
This alliance aims to provide life sciences companies with real-time intelligence and critical insights to enhance decision-making throughout the product lifecycle.
Combining Deep Oncology Data with Advanced Commercial Analytics
The partnership integrates Trinity’s advanced commercial analytics with Ontada’s proprietary iKnowMed electronic health record (EHR) platform. iKnowMed captures deep, multidimensional oncology data, enabling the rapid generation of commercial insights.
These insights will support smarter, faster decisions that ultimately improve patient outcomes and business impact.
Empowering Strategy Across the Patient Journey
The collaboration offers enhanced capabilities in patient journey mapping, provider segmentation, forecasting, and customer targeting. Life sciences companies can better understand the complex landscape of community oncology and allocate resources more effectively.
“Understanding community oncology presents a particular challenge for commercial teams as they work to develop strategies and deploy resources to maximize adoption of life-saving therapies. Ontada’s data, coupled with Trinity’s analytical services, allows the extraction of deeper, more actionable insights and powers more impactful commercial decision-making that will help to optimize patient outcomes.”
- Leslie Orne, president and CEO of Trinity Life Sciences
Innovation Driven by AI and Real-World Data
Trinity brings oncology expertise across forecasting, real-world analytics, and primary market research. Their AI-enhanced solutions are tailored to meet the evolving needs of life sciences companies, enabling scalable and transformational strategies in launch, customer engagement, medical affairs, and GenAI applications.
“The need for rapid insights in cancer care has never been greater. Ontada’s collaboration with Trinity demonstrates our commitment to delivering faster answers to critical questions. By connecting Trinity’s robust analytics with Ontada’s nuanced and unique data sets, we can provide deeper, more actionable insights for our life science partners. Speed is crucial not only to our life science partners but also for cancer patients, who can benefit greatly from a better understanding of precision therapies.”
- Christine Davis, president of Ontada
Unique Access to Community Oncology Data
Ontada’s real-world oncology data reflects over 2.4 million patient records across more than 80 tumor types, sourced from The US Oncology Network and Onmark practices.
Its iKnowMed EHR is used by more than 2,400 oncology providers across the United States, offering a unique view into community-based cancer care and enabling data-driven improvements in patient outcomes.

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!